Test ID BRAFD BRAF V600E/V600K Somatic Mutation Analysis, Tumor
Necessary Information
Pathology report (final or preliminary) must accompany specimen in order for testing to be performed. At minimum, it should contain the following information:
1. Patient name
2. Block number-must be on all blocks, slides and paperwork (can be handwritten on the paperwork)
3. Tissue collection date
4. Source of the tissue
Specimen Required
Preferred:
Specimen Type: Tissue
Container/Tube: Tissue block
Collection Instructions: Submit a formalin-fixed, paraffin-embedded tissue block.
Acceptable:
Specimen Type: Tissue
Container/Tube: Slides
Specimen Volume: 1 stained and 5 unstained
Collection Instructions: Submit 1 slide stained with hematoxylin and eosin and 5 unstained, nonbaked slides with 5-micron thick sections of the tumor tissue.
Useful For
Therapy selection for patients with cancer (eg, melanomas that may respond to BRAF inhibitors, colon cancers than may not respond to EGFR inhibitors)
Aiding in the diagnosis/prognosis of certain cancers (eg, hairy cell leukemia, papillary thyroid cancers, and association with aggressiveness)
Aid in determining risk for Lynch syndrome (eg, an adjunct to negative MLH1 germline testing in cases where colon tumor demonstrates MSI-H and loss of MLH1 protein expression)
Additional Tests
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
SLIRV | Slide Review in MG | No, (Bill Only) | Yes |
Testing Algorithm
When this test is ordered, slide review will always be performed at an additional charge.
See Lynch Syndrome Testing Algorithm in Special Instructions.
Special Instructions
Method Name
Digital Droplet Polymerase Chain Reaction (ddPCR)
Reporting Name
BRAF V600 Somatic Mutation Analysis, TumorSpecimen Type
VariesSpecimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Varies | Ambient (preferred) | ||
Refrigerated |
Day(s) Performed
Monday through Friday
Report Available
5 to 7 daysPerforming Laboratory

Test Classification
This test was developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
81210
88381-Microdissection, manual
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
BRAFD | BRAF V600 Somatic Mutation Analysis, Tumor | 97025-1 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
608306 | Result Summary | 50397-9 |
608307 | Result | 97025-1 |
608308 | Interpretation | 69047-9 |
608309 | Additional Information | 48767-8 |
608310 | Specimen | 31208-2 |
608311 | Source | 31208-2 |
608312 | Released By | 18771-6 |
608235 | Method | 85069-3 |
608222 | Tissue ID | 80398-1 |
606746 | Disclaimer | 62364-5 |
Reference Values
An interpretive report will be provided.
Forms
If not ordering electronically, complete, print, and send an Oncology Test Request (T729) with the specimen.